Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387493529> ?p ?o ?g. }
- W4387493529 endingPage "1805" @default.
- W4387493529 startingPage "1805" @default.
- W4387493529 abstract "Background and Objectives: We have recently reported that Fluvastatin, Atorvastatin, Simvastatin and Rosuvastatin have calcium channel antagonistic activities using rabbits’ intestinal preparations. The current study is focused on the effects of Pitavastatin and Lovastatin for possible inhibition of vascular L-Type calcium channels, which may have vasorelaxant effect(s). Combined effects of Pitavastatin and Lovastatin in the presence of Amlodipine were also tested for vasorelaxation. Materials and Methods: Possible relaxing effects of Pitavastatin and Lovastatin on 80 mM Potassium chloride (KCL)-induced contractions and on 1 µM norepinephrine (N.E)-induced contractions were studied in isolated rabbit’s aortic strips preparations. Relaxing effects on 80 mM KCL-induced vascular contractions were further verified by constructing Calcium Concentration Response Curves (CCRCs), in the absence and presence of three different concentrations of Pitavastatin and Lovastatin using CCRCs as negative control. Verapamil was used as a standard drug that has L-Type calcium channel binding activity. In other series of experiments, we studied drug interaction(s) among Pitavastatin, Lovastatin, and amlodipine. Results: The results of this study imply that Lovastatin is more potent than Pitavastatin for having comparatively lower EC50 (7.44 × 10−5 ± 0.16 M) in intact and (4.55 × 10−5 ± 0.10 M) in denuded aortae for KCL-induced contractions. Lovastatin amplitudes in intact and denuded aortae for KCL-induced contractions were, respectively, 24% and 35.5%; whereas amplitudes for Pitavastatin in intact and denuded aortae for KCL-induced contractions were 34% and 40%, respectively. A left shift in the EC50 values for the statins was seen when we added amlodipine in EC50 (Log Ca++ M). Right shift for CCRCs state that Pitavastatin and Lovastatin have calcium channel antagonistic effects. Lovastatin in test concentration (6.74 × 10−7 M) produced a right shift in relatively lower EC50 (−2.5 ± 0.10) Log Ca++ M as compared to Pitavastatin, which further confirms that lovastatin is relatively more potent. The right shift in EC50 resembles the right shift of Verapamil. Additive effect of Pitavastatin and Lovastatin was noted in presence of amlodipine (p < 0.05). Conclusions: KCL (80 mM)-induced vascular contractions were relaxed by Pitavastatin and Lovastatin via inhibitory effects on L-Type voltage-gated calcium channels. Lovastatin and Pitavastatin also relaxed Norepinephrine (1 µM)-induced contractions giving an insight for involvement of dual mode of action of Pitavastatin and Lovastatin." @default.
- W4387493529 created "2023-10-11" @default.
- W4387493529 creator A5026094168 @default.
- W4387493529 creator A5040931855 @default.
- W4387493529 creator A5053949049 @default.
- W4387493529 creator A5059585920 @default.
- W4387493529 creator A5079004915 @default.
- W4387493529 date "2023-10-10" @default.
- W4387493529 modified "2023-10-12" @default.
- W4387493529 title "Pitavastatin and Lovastatin Exhibit Calcium Channel Blocking Activity Which Potentiate Vasorelaxant Effects of Amlodipine: A New Futuristic Dimension in Statin’s Pleiotropy" @default.
- W4387493529 cites W127809968 @default.
- W4387493529 cites W1500847299 @default.
- W4387493529 cites W1500963439 @default.
- W4387493529 cites W1989300559 @default.
- W4387493529 cites W2006966124 @default.
- W4387493529 cites W2015995918 @default.
- W4387493529 cites W2024132287 @default.
- W4387493529 cites W2029605351 @default.
- W4387493529 cites W2038261200 @default.
- W4387493529 cites W2039944972 @default.
- W4387493529 cites W2074931144 @default.
- W4387493529 cites W2091635613 @default.
- W4387493529 cites W2092480122 @default.
- W4387493529 cites W2103636227 @default.
- W4387493529 cites W2107841008 @default.
- W4387493529 cites W2125149319 @default.
- W4387493529 cites W2129750583 @default.
- W4387493529 cites W2146311281 @default.
- W4387493529 cites W2147454356 @default.
- W4387493529 cites W2297753288 @default.
- W4387493529 cites W2518799467 @default.
- W4387493529 cites W2591717198 @default.
- W4387493529 cites W3111930466 @default.
- W4387493529 cites W3141158439 @default.
- W4387493529 cites W4239047758 @default.
- W4387493529 cites W4307029498 @default.
- W4387493529 cites W4378470103 @default.
- W4387493529 doi "https://doi.org/10.3390/medicina59101805" @default.
- W4387493529 hasPublicationYear "2023" @default.
- W4387493529 type Work @default.
- W4387493529 citedByCount "0" @default.
- W4387493529 crossrefType "journal-article" @default.
- W4387493529 hasAuthorship W4387493529A5026094168 @default.
- W4387493529 hasAuthorship W4387493529A5040931855 @default.
- W4387493529 hasAuthorship W4387493529A5053949049 @default.
- W4387493529 hasAuthorship W4387493529A5059585920 @default.
- W4387493529 hasAuthorship W4387493529A5079004915 @default.
- W4387493529 hasBestOaLocation W43874935291 @default.
- W4387493529 hasConcept C126322002 @default.
- W4387493529 hasConcept C134018914 @default.
- W4387493529 hasConcept C185592680 @default.
- W4387493529 hasConcept C2776329913 @default.
- W4387493529 hasConcept C2776692505 @default.
- W4387493529 hasConcept C2776839432 @default.
- W4387493529 hasConcept C2777022698 @default.
- W4387493529 hasConcept C2777482532 @default.
- W4387493529 hasConcept C2778163477 @default.
- W4387493529 hasConcept C2778417548 @default.
- W4387493529 hasConcept C2779646130 @default.
- W4387493529 hasConcept C2779918671 @default.
- W4387493529 hasConcept C2780437262 @default.
- W4387493529 hasConcept C2780940807 @default.
- W4387493529 hasConcept C519063684 @default.
- W4387493529 hasConcept C55493867 @default.
- W4387493529 hasConcept C71924100 @default.
- W4387493529 hasConcept C84393581 @default.
- W4387493529 hasConcept C85520022 @default.
- W4387493529 hasConcept C98274493 @default.
- W4387493529 hasConceptScore W4387493529C126322002 @default.
- W4387493529 hasConceptScore W4387493529C134018914 @default.
- W4387493529 hasConceptScore W4387493529C185592680 @default.
- W4387493529 hasConceptScore W4387493529C2776329913 @default.
- W4387493529 hasConceptScore W4387493529C2776692505 @default.
- W4387493529 hasConceptScore W4387493529C2776839432 @default.
- W4387493529 hasConceptScore W4387493529C2777022698 @default.
- W4387493529 hasConceptScore W4387493529C2777482532 @default.
- W4387493529 hasConceptScore W4387493529C2778163477 @default.
- W4387493529 hasConceptScore W4387493529C2778417548 @default.
- W4387493529 hasConceptScore W4387493529C2779646130 @default.
- W4387493529 hasConceptScore W4387493529C2779918671 @default.
- W4387493529 hasConceptScore W4387493529C2780437262 @default.
- W4387493529 hasConceptScore W4387493529C2780940807 @default.
- W4387493529 hasConceptScore W4387493529C519063684 @default.
- W4387493529 hasConceptScore W4387493529C55493867 @default.
- W4387493529 hasConceptScore W4387493529C71924100 @default.
- W4387493529 hasConceptScore W4387493529C84393581 @default.
- W4387493529 hasConceptScore W4387493529C85520022 @default.
- W4387493529 hasConceptScore W4387493529C98274493 @default.
- W4387493529 hasIssue "10" @default.
- W4387493529 hasLocation W43874935291 @default.
- W4387493529 hasOpenAccess W4387493529 @default.
- W4387493529 hasPrimaryLocation W43874935291 @default.
- W4387493529 hasRelatedWork W1833059984 @default.
- W4387493529 hasRelatedWork W1975251706 @default.
- W4387493529 hasRelatedWork W1978518128 @default.
- W4387493529 hasRelatedWork W2033975223 @default.
- W4387493529 hasRelatedWork W2087463005 @default.
- W4387493529 hasRelatedWork W2129480184 @default.